JW Life Science

JW Life Science Current Liabilities

The Current Liabilities of JW Life Science (234080.KS) as of Oct 16, 2026 is 16.90 B KRW. In the previous year, Current Liabilities was 22.57 B KRW — a change of -25.13% (lower).

Current Liabilities

16.90 BKRW

YoY

-25.13%

Last updated:

Current Liabilities of JW Life Science is 2025 16.90 B KRW. Current Liabilities of JW Life Science was 2024 22.57 B KRW. It decreases by -25.13% lower compared to the previous year.

The JW Life Science Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
79.27 B KRW
Jan 1, 2019
72.76 B KRW
Jan 1, 2020
38.06 B KRW
Jan 1, 2021
40.43 B KRW
Jan 1, 2022
33.03 B KRW
Jan 1, 2023
51.71 B KRW
Jan 1, 2024
22.57 B KRW
Jan 1, 2025
16.90 B KRW
The JW Life Science Current Liabilities history
YEARCurrent LiabilitiesYoY
16.90 BKRW-25.13%
22.57 BKRW-56.34%
51.71 BKRW+56.57%
33.03 BKRW-18.30%
40.43 BKRW+6.21%
38.06 BKRW-47.68%
72.76 BKRW-8.22%
79.27 BKRW-1.31%
80.33 BKRW-2.11%
82.06 BKRW+252.14%
23.30 BKRW-69.82%
77.21 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JW Life Science Stock analysis

What does JW Life Science do? JW Life Science Corp is a South Korean pharmaceutical company headquartered in Dangjin. The company manufactures intravenous fluids including basic IV fluids with water, electrolytes, and glucose; nutrient infusion solutions containing amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions for specific medical cases. It also produces total parenteral nutrition (TPN) products. The company went public on October 27, 2016, with its stock listed on the Korea Exchange under ticker 234080.KS. Its ISIN is KR723080000. The company's website is https://www.jw-lifescience.co.kr/ JW Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JW Life Science stock

Current Liabilities of JW Life Science is 16.90 B KRW in 2025.

Current Liabilities of JW Life Science changed from 22.57 B KRW to 16.90 B KRW, representing a -25.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities JW Life Science since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's JW Life Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — JW Life Science

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — JW Life Science